Tag Archives: human papillomavirus

August, 2018

June, 2018

December, 2017

  • 18 December

    Regeneron and ISA Pharmaceuticals Enter Strategic Immuno-Oncology Collaboration

    TARRYTOWN, N.Y. and LEIDEN, The Netherlands, Dec. 18, 2017 /PRNewswire/ — Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and ISA Pharmaceuticals B.V., a clinical-stage immunotherapy company, today announced a clinical collaboration to advance ISA101, an immunotherapy targeting human papillomavirus type 16 (HPV16)-induced cancer, in combination with cemiplimab (REGN2810), a PD-1 (programmed cell death protein 1) antibody. Regeneron and ISA …

January, 2016